[BIC-announce] FW: Killam Lecture - Tomorrow - Human Embryonic Stem Cell Derviates for the Treatment of Spinal Cord Injury and Disease

[Jennifer Chew, Ms.]

PLEASE DISCARD IF THIS IS A DUPLICATE.  THANK YOU.  JENNIFER 
 

Jennifer Chew

McConnell Brain Imaging Centre

MNI - WB317

3801 University Street

Montreal, Qc  H3A 2B4

Telephone:  514-398-8554

Fax:  514-398-2975

 

 

________________________________

From: MNISTAFF - Montreal Neurological Institute Staff [mailto:MNISTAFF at LISTS.MCGILL.CA] On Behalf Of Enza Ferracane, Ms.
Sent: Monday, February 01, 2010 3:50 PM
To: MNISTAFF at LISTS.MCGILL.CA
Subject: Killam Lecture - Tomorrow



Killam Lecture

 

Speaker:  Hans Keirstead, PhD, 

Department of Anatomy & Neurobiology

University of California, Irvine

 

Title:  Human Embryonic Stem Cell Derviates for the Treatment of Spinal Cord Injury and Disease

 

Time:  4:00 PM

 

Date: Tuesday, February 2, 2010

 

Place:  de Grandpre Communications Centre

 

Dr. Hans Keirstead is Associate Professor of Anatomy and Neurobiology and Co-Director of the Sue and Bill Gross Stem Cell Research Center at the UC Irvine Reeve-Irvine Research Center. In 2004, Hans Keirstead led his team of researchers at UC Irvine to successfully develop a human embryonic stem cell derived treatment for acute spinal cord injuries in rats. That treatment was recently approved by FDA for clinical trials in humans with acute spinal cord injuries. The trial, which will be carried out by Geron Corporation, marks the first human embryonic stem cell trial ever approved in the U.S. 

 

 

Enza Ferracane

Montreal Neurological Institute

3801 University

Montreal, Quebec  H3A 2B4

Director's Office, Rm 636

Tel: (514) 398-1903

Fax:  (514) 398-8248

Email: enza.ferracane at mcgill.ca <mailto:enza.ferracane at mcgill.ca>